Cell therapy company Link Cell Therapies is launching with $60 million and a mission to develop potent CAR-T therapies that ...
GM announced on Friday that it’s ceasing work on next-generation fuel cell development through the HYDROTEC brand. HYDROTEC is the branding that GM has used previously for hydrogen fuel cell projects ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company's CRISPR-based ...
Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced today a distribution partnership to ...
The gene therapy developer has lost most of its value since going public in 2020 and saw a long road ahead for a delivery ...
Hosted on MSN
Next-gen CAR-T cell therapy shows early promise in patients with refractory B-cell acute lymphoblastic leukemia
Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational next-generation CD19-directed CAR-T cell therapy that is manufactured in 48 hours using ...
From silver nanofibers to smart, sensory-packed dressings, the next generation of wound-healing technology is blurring the line between biology and engineering. A new review has looked at what’s ...
When asked what Moleculent’s cell-cell interaction mapping technology provides to translational researchers, CEO Olle Ericsson explained that it adds “a new layer of information,” specifically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback